The prevalence of suicidal ideation identified by the Edinburgh Postnatal Depression Scale in postpartum women in primary care: findings from the RESPOND trial by Howard, Louise M et al.
RESEARCH ARTICLE Open Access
The prevalence of suicidal ideation identified by
the Edinburgh Postnatal Depression Scale in
postpartum women in primary care: findings
from the RESPOND trial
Louise M Howard
1*, Clare Flach
1, Anita Mehay
1, Debbie Sharp
2 and Andre Tylee
1
1 Abstract
1.1 Background: Suicide is a leading cause of perinatal maternal deaths in industrialised countries but there has
been little research to investigate prevalence or correlates of postpartum suicidality. The Edinburgh Postnatal
Depression Scale is widely used in primary and maternity services to screen for perinatal depressive disorders, and
includes a question on suicidal ideation (question 10). We aimed to investigate the prevalence, persistence and
correlates of suicidal thoughts in postpartum women in the context of a randomised controlled trial of treatments
for postnatal depression.
1.2 Methods: Women in primary care were sent postal questionnaires at 6 weeks postpartum to screen for
postnatal depression before recruitment into an RCT. The Edinburgh Postnatal Depression Scale (EPDS) was used to
screen for postnatal depression and in those with high levels of symptoms, a home visit with a standardised
psychiatric interview was carried out using the Clinical Interview Schedule-Revised version (CIS-R). Other socio-
demographic and clinical variables were measured, including functioning (SF12) and quality of the marital
relationship (GRIMS). Women who entered the trial were followed up for 18 weeks.
1.3 Results: 9% of 4,150 women who completed the EPDS question relating to suicidal ideation reported some
suicidal ideation (including hardly ever); 4% reported that the thought of harming themselves had occurred to
them sometimes or quite often. In women who entered the randomised trial and completed the EPDS question
relating to suicidal ideation (n = 253), suicidal ideation was associated with younger age, higher parity and higher
levels of depressive symptoms in the multivariate analysis. Endorsement of ‘yes, quite often’ to question 10 on the
EPDS was associated with affirming at least two CIS-R items on suicidality. We found no association between
suicidal ideation and SF-12 physical or mental health or the EPDS total score at 18 weeks.
1.4 Conclusions: Healthcare professionals using the EPDS should be aware of the significant suicidality that is
likely to be present in women endorsing ‘yes, quite often’ to question 10 of the EPDS. However, suicidal ideation
does not appear to predict poor outcomes in women being treated for postnatal depression.
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Suicide is a leading cause of maternal deaths in the peri-
natal period in industrialised countries [1,2]. Suicide is
more common in people with suicidal thoughts [3] and
suicidal thoughts are therefore a cause for concern
when elicited by health professionals. Outside of the
perinatal period, being female and having major depres-
sion are associated with the highest risk of acting on
suicidal ideas [4] but there is some evidence that com-
pared with non-pregnant populations, women in the
antenatal and postnatal period are at lower risk, with
risk being highest in women with severe disorders [5].
This may be due to concern for the unborn child being
a protective factor or may reflect that women with a
high risk of suicide are less likely to get pregnant. The
relationship between suicidal thoughts and suicidal acts
in the postpartum period is not clear but it is prudent
to assume that suicidal thoughts are a marker of
increased risk of suicide [5].
There has been little research to investigate correlates
of suicidality in the postpartum period, but in primary
care suicidal ideation is associated with functional
impairment, psychiatric comorbidity, increased health
service use and subjective distress [6-8]. A review of stu-
dies of suicidality in the perinatal period found the pre-
valence in the postnatal period to vary from 4% (in
Finland) to 15% (in India) [5]; all of these studies used
the Edinburgh Postnatal Depression Scale (EPDS) [9]
which includes a specific item on self harming thoughts
on a four point scale ‘never’, ‘hardly ever’, ‘sometimes’,
‘yes quite often’. However in all but one study, the study
population was relatively small (< 900 women) and no
other measure of suicidality was used to compare with
the EPDS measure. A more recent study used the Beck
Depression Inventory (BDI9) [10] in a population based
sample of married women and found endorsement of
t h es e l fh a r mq u e s t i o ni n8 . 3 %o f3 8 6w o m e n[ 1 1 ] ;i n
their multivariate analysis of its correlates, only a posi-
tive BDI was retained as a risk factor for suicidality but
they acknowledged that the study may not have had the
statistical power to detect correlates due to the limited
sample size. There is therefore limited information on
risk factors associated with an EPDS measure of suicid-
ality or persistence of such suicidality. Previous studies
have also not examined whether suicidal ideation is
associated with worse outcome.
The Edinburgh Postnatal Depression Scale (EPDS) [9]
is a widely used tool in primary care and community
maternity services to screen for depressive disorders in
the perinatal period [12]. There is growing evidence that
it also identifies anxiety disorders [13]. Although there
is some controversy about whether and when to use the
EPDS in screening for postnatal mental disorders
[14,15] it is still used internationally in the primary care
setting. We used the EPDS to identify women in the
community who were possibly depressed, for recruit-
ment into a randomised controlled trial comparing anti-
depressants and non - directive counselling in the
treatment of postnatal depression (the RESPOND trial)
[16]. This enabled us to investigate the prevalence of
suicidal thoughts in postpartum women, the persistence
and correlates of suicidal thoughts in postpartum
women participating in a treatment trial, and to com-
pare the EPDS measure of suicidality with the more
comprehensive assessment used as part of the Clinical
Interview Schedule-Revised version (CIS-R) [17].
We aimed to:
1) determine the prevalence of suicidal ideation as
measured by the EPDS in a primary care population
of women at 6-8 weeks postpartum screened for
postnatal depressive symptoms before being offered
the opportunity to enter the RESPOND trial, and
determine the persistence of suicidal ideation at 18
weeks postpartum in those that did enter the trial;
2) validate the EPDS measure of suicidal ideation
using the more detailed Clinical Interview Schedule-
Revised version (CIS-R) measure of suicidality;
3) determine risk factors associated with the EPDS
measure of suicidality in women participating in
RESPOND;
4) examine whether suicidal ideation is associated
with worse outcome (quality of life; depressive symp-
toms on EPDS; quality of marital relationship) at fol-
low-up during the RESPOND trial.
We hypothesised that:
a) EPDS suicidal ideation at 6-8 weeks postpartum is
associated with high levels of depressive symptoms
at 6-8 weeks
b) EPDS suicidal ideation at 6-8 weeks postpartum is
associated with risk factors for depression (young
age, unemployment and lack of a partner)
c) EPDS suicidal ideation at 6-8 weeks postpartum is
associated with worse outcome 18 weeks later in
women being treated for postnatal depression
2 Methods
Study design: prospective cohort study nested within an
RCT.
Participants
Study population
Postpartum women registered with general practitioners
in 77 collaborating practices in the UK located in Bristol
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tices) and Manchester (35 practices) were eligible for
the trial. These practices served a wide range of neigh-
bourhoods including both affluent and socioeconomi-
cally deprived urban areas. Recruitment took place
between January 2005 and Aug 2007,
Inclusion criteria: recently-delivered women aged 18
years or over who had a live birth and were living with
their baby.
Exclusion criteria: women who had a stillbirth or neo-
natal death; women whose baby was more than 26
weeks old or whose baby had been fostered or adopted;
women with psychosis, alcohol or drug abuse; women
receiving treatment for depression.
Recruitment procedure (see figure 1)
Initial postal screening
All eligible women were identified by clerical assistants
at their registered general practice (primary health care
centre) as notification of all births is sent to the prac-
tices by maternity services and public health services.
Practice health visitors checked that women were eligi-
ble before the invitation pack to participate in the main
RESPOND trial was sent from the GP just before their
baby was six weeks old. This invitation pack included a
screening EPDS questionnaire. Responses to the EPDS
provided at this stage are used to determine an overall
prevalence of suicidal ideation in postnatal women.
Only eligible, consenting women who had scored 11 or
more on the screening EPDS were invited to participate
in a home visit to assess further their eligibility for the
main RESPOND trial (see Figure 1).
Home visit (baseline)
Once a potentially eligible woman was identified for
entry into the main RESPOND trial, a Research Associ-
ate would contact the woman and ask if she agreed to a
home visit. If a woman consented this was usually con-
ducted at between eight and ten weeks postpartum;
however women could receive a home visit up to 26
weeks postpartum. Women completed a baseline EPDS,
the revised computerised Clinical Interview Schedule
(CIS-R) [17] and a quality of life measure (SF12) (Ware
et al, 1996). However, at the start of the trial, women
who scored below 13 on the EPDS were not always
asked to complete the CIS-R and SF12 so these data are
not available for all women who received a home visit.
Demographic data were collected by self-report
questionnaire.
Follow-up schedule
Follow-ups were scheduled at 4 weeks and 18 weeks
after the home visit for randomised women participating
in the RESPOND trial. At these time points, postal
questionnaires were sent to collect outcome measure-
ments (including the EPDS and SF-12).
Measures
Diagnosis of depression and assessment for suicidal
ideation (see Additional File 1: appendix 1 for protocol
of SI care)
The Edinburgh Postnatal Depression Scale (EPDS) [9], a
10 item self-report questionnaire, was used to screen for
postnatal depression. The case definition for probable
depression is a score of ≥13. ‘Suicidal ideation’ (SI) was
defined as an answer of ‘Sometimes’ or ‘Yes, quite often’ to
question 10 of the EPDS ‘The thought of harming myself
has occurred to me’. ‘No suicidal ideation’ was defined by
answering ‘hardly ever’ or ‘never’ for question 10. The
EPDS was completed at the screening stage, the baseline
home visit, and at the 4 and 18 week follow-ups.
The self-administered computerised version of the
CIS-R was used at baseline to obtain a more accurate
measure of the woman’s clinical state, to confirm a diag-
nosis of depression. The CIS-R is a fully structured psy-
chiatric assessment for 14 common symptoms of
depression and anxiety in the week before interview.
Suicidal ideation is asked about in the following
questions:
Have you felt hopeless at all during the PAST SEVEN
DAYS, for instance about your future? (Yes/No)
In the PAST SEVEN DAYS, have you felt that life isn’t
worth living? (no/sometimes/always)
In the PAST WEEK, have you thought of killing your-
self? (no/yes - but I wouldn’t commit suicide/yes)
In the PAST WEEK, Have you thought about a way in
which you might kill yourself? (yes/no)
We coded this as 0 (no suicidal thoughts) or 1-4
(endorsement of one, two, three or four of the questions
above)
Mental and physical health status
Mental and physical health status was assessed at base-
line and at both follow-ups and measured using the
standard SF-12 version 2 questionnaire [18]. This 12-
item measure is a widely used and well validated generic
measure of functioning. Mental and physical component
scores were calculated using standard algorithms, with
higher scores indicating better functioning.
Quality of relationship
Quality of relationship was assessed at baseline and at
both follow-ups using the Golombok-Rust Inventory of
Marital State (GRIMS) [19]. This instrument is a 28-
item questionnaire to assess the overall quality of a cou-
ple’s relationship with higher scores indicating poorer
quality of relationship. The measure has been shown to
have good reliability (Cronbach’s alpha of 0.92 in men
and 0.89 in women).
Socio-demographic measures
Data were also collected on marital and co-habiting sta-
tus, educational level, employment status of women and
partner, ethnicity and parity.
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Page 3 of 10EPDS returned     EPDS not returned
    
EPDS<11                               EPDS11
            Excluded                  Not excluded
Not eligible 
                                                              Eligible                            
                                                        ICD-10 Depression  
                                                                       EPDS 13                        
Note: If suicide ideation was reported at any stage in this process the self-harm protocol was implemented
(Appendix 1) 
PCT/hospital birth 
notification
Direct referral from GP or PHV 
26 weeks post-delivery
PHV assesses the suitability for inclusion i.e.
excludes still birth or neonatal death, foster 
care or adoption
Invitation, consent form and 
screening EPDS sent by GP practice
(when baby is 5-6 weeks old)
Baseline Home Visit
Eligibility EPDS and CIS-R
Demographic data
Screening EPDS returned by woman
GP reviews exclusion criteria GP/PHV informed of EPDS score
Randomised
Further baseline measures
Woman: SF-12, GRIMS, MAMA, EQ-5D
Partner: SF-12, GRIMS, PAPA, GHQ-12
Reminder sent
Figure 1 Summary of RESPOND recruitment procedures. Flow chart of trial recruitment procedures from initial birth notification to
randomization.
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We defined suicidal ideation (SI) in these women as the
thought of harming themselves “sometimes” or “quite
often” as indicated in the response to question 10 of the
EPDS. We defined a ‘suicidal case’ as measured by the
CIS-R as identifying 2 or more items on the CIS-R. The
outcome measures investigated in the sub-group of
women who participated in the RESPOND trial were
the SF-12 physical health subscale, SF-12 mental health
subscale and EPDS at 18 weeks.
We estimated the prevalence of SI in the complete
sample of all women surveyed at the point of screening,
using frequencies and proportions. We investigated the
persistence of SI in the sub-group of women who
entered the trial and were followed up to 18 weeks, by
the association between SI in women at home visit base-
line, with SI 4 weeks and 18 weeks later using chi-
squared tests for the two outcomes, with and without
adjustment for treatment allocation. To assess the agree-
ment between the CIS-R measure of suicidality and
EPDS SI in women who had measures of both the CIS-
R and the EPDS, we tabulated the two measures on
their full scores. We used a chi-square test of the two
measures using their full range of categories (0-3 for
EPDS and 0-4 for CIS-R) and assessed agreement
between suicidal caseness as measured by the CIS-R and
EPDS SI using a kappa statistic.
To investigate the ability of SI at baseline to predict
outcome at 18 weeks in women who had entered
RESPOND study, we first summarised the characteris-
tics (age, ethnicity, marital status, living status, parity,
employment, education and health measures) of those
with and without SI at baseline, testing for differences
using t-tests and chi-squared tests. We employed these
measures in a multivariable logistic regression to investi-
gate variables associated with SI in a cross-sectional ana-
lysis to be adjusted for as potential confounders in the
follow-up analysis. We then investigated baseline predic-
tors of loss to follow up and any factors found to be
associated were included in the 18 week analysis. We
conducted a linear regression of the clinical outcome
measures SF-12 physical health subscale, SF-12 mental
health subscale and EPDS at 18 weeks after baseline
separately adjusting for the relevant baseline measure,
suicidal ideation and treatment allocation and then addi-
tionally adjusting for variables associated with baseline
suicidal ideation. (No factors were found to be asso-
ciated with loss to follow-up and so no further adjust-
ment was necessary).
Ethical approval
T h et r i a lw a sa p p r o v e db yt he Scotland Multi-centre
Research Ethics Committee (MREC; reference number
MREC/03/0/127) and site-specific approval was obtained
from the 10 relevant local ethics committees and 10 Pri-
mary Care Trusts (PCTs).
3 Results
3.1 Prevalence and persistence of suicidal ideation
4173 women returned the screening questionnaire
and of these, a total of 4,150 women completed the
EPDS question relating to suicidal ideation (SI) (n =
23, 0.5% missing) (see Figure 2 for flow chart of
women through the RESPOND study). Nine percent
(95%CI 8.3% -10.1%) (n = 374) reported any suicidal
ideation (including hardly ever) and 4% (95% CI 3.2%
- 4.4%) reported that the thought of harming them-
selves had occurred to them sometimes or quite
often. The latter group (i.e. reporting that the thought
of harming themselves occurred sometimes or often)
are defined in this study as experiencing SI. Of those
that had SI at home visit and entered the trial (i.e.
had a CIS-R primary diagnosis of depression) (n =
32), 56% also reported it at 4 weeks compared to only
9 %o ft h o s et h a td i dn o th a v eS Ia tb a s e l i n e( p<
0.001 (either unadjusted or adjusted for treatment
allocation). At 18 weeks follow-up, only 15% of those
with SI at baseline also had it at 18 weeks, which is
not significantly different to those without SI at base-
line (6%, p = 0.075 adjusted for treatment allocation,
(see table 1). No difference in prevalence of SI report-
ing was seen between the treatment groups at either
baseline (p = 0.635), 4 weeks (p = 0.431) or 18 weeks
(p = 0.769) follow-up.
3.2 Validity of EPDS measure of suicidal ideation
We compared the 5 level CIS-R suicidal ideation mea-
sure to the 4 level EPDS suicidal ideation measure
(table 2) for those women who had a home visit and
were administered both measures (n = 331). We also
considered dichotomised definitions of “SI cases” as
“sometimes/often have suicidal thoughts” on the EPDS
and “CIS-R suicidal casesness as endorsement of 2 or
more items on the CIS-R. The two measures are sig-
nificantly associated (chi
2 statistic = 145.81, p < 0.001).
Almost all (99%) women reporting ‘never/hardly ever
have suicidal thoughts’ on the EPDS question reported
positively to 2 or fewer items out of 4 on the CIS-R SI
questions. All women who reported significant SI on
the EPDS (i.e. often had thoughts of self-harm)
reported a score of 2 or more on the CIS-R measure
of suicidality. However only 68% of those who “some-
times” considered harming themselves on the EPDS
scored positively to 2 or more items on the CIS-R.
Defining a suicidal ‘case’ from the CIS-R as responding
positively to 2 or more items agrees with the EPDS
definition in 79% of cases and gives a moderate kappa
statistic of 0.42.
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Women who entered the randomised trial (n = 254)
(and therefore had an EPDS≥13 and a CIS-R primary
diagnosis of depression at home visit) had more detailed
sociodemographic and clinical data, enabling us to
examine which sociodemographic and clinical variables
were associated with SI in this group at baseline. One
woman did not complete question 10 of the EPDS and
so was not included, leaving 253 women for the remain-
ing analyses (though not all 253 women completed the
baseline SF12 - n = 227; ie 90%). There was a small
amount of drop-out over the follow-up period, 218
(86%) participants completed the 4 week assessment and
206 (81%) completed the 18 week assessment. Compari-
sons between those with and without follow-up at 18
weeks indicated no baseline variables were significantly
associated with attrition at the 5% level of significance.
I nt h eu n i v a r i a t ea n a l y s i s ,w ef o u n dt h a tw o m e nw e r e
more likely to experience suicidal ideation at baseline if
they were younger, unmarried, unemployed or had a
partner that was unemployed. They were also more
l i k e l yt oh a v eah i g h e rs c o r eo nt h eG R I M S( r e f l e c t i n g
poorer quality of the relationship with partner)and the
EPDS and lower (worse) score on the SF-12 mental
component (table 3). After multivariate analysis, includ-
ing all measures (age, ethnicity, marital status, living sta-
tus, parity, employment, educational level and health
measures), adjusted odds ratios remained significant for
age and EPDS (see table 3)
We found no association between suicidal ideation at
baseline and any of the three outcomes at 18 weeks -
SF-12 physical or mental health or the EPDS total score,
when adjusted only for the baseline measure and treat-
ment allocation (Table 4). After additional adjustment
for variables associated with suicidal ideation at baseline
and loss to follow-up (age, current employment, partner
employment and marital status) there was still no asso-
ciation found between suicidal ideation and outcome.
4 Discussion
We found that 4% of 4150 women in the community at
around 6 weeks postpartum had suicidal ideation (SI)
occurring sometimes or quite often, and 9% reported
any suicidal ideation. This is a higher prevalence of sig-
nificant SI than reported by previous studies in Finland
and England [5] and this may reflect our study sample
which was recruited from areas with higher levels of
socioeconomic deprivation than in previous studies [16].
Endorsement of ‘yes, quite often’ SI on question 10 of
the EPDS was associated with affirming at least two
CIS-R items on suicidality. However, endorsement of
‘sometimes’ experiencing SI was not concordant with
suicidality as measured by the CIS-R; the kappa statistic
of 0.42 reflects this moderate level of agreement. We
also confirmed that in women with an EPDS > 12 and a
diagnosis of depression, women participating in a treat-
ment trial for postnatal depression were more likely to
experience SI if they had more depressive symptoms as
measured on the EPDS; in addition they were more
likely to be younger, unmarried, unemployed or have an
unemployed partner, and have marital problems. In the
multivariable analysis, younger age, having 3 or more
Invitations 
sent by GPs
N = 10 604
Number of 
replies
N =4 328 (41%)
Declined EPDS 
screening
N = 155 (4%)
Returned EPDS 
or direct referral
N = 4 137
EPDS  11 or 
referral
N = 989
EPDS < 11
N = 3 184
Refused/did not 
reply
N = 181 Already on 
treatment
N = 88
Excluded by 
GP/HV
N = 21
Other exclusion 
criteria
N = 71
Home visit 
assessments
N = 628*
Already on 
treatment
N = 6
Home visit EPDS 
< 13
N = 298 (47%)
Excluded by 
GP/HV
N = 7
No ICD-10 
diagnosis
N = 54
Other exclusion 
criteria
N = 1
Refused 
randomisation
N = 8
Number 
randomised
N = 254
Number included 
in analysis
N = 253
No Q10 EPDS
N = 1
Number followed 
up at 4 weeks
N= 218 (86%)
Number followed 
up at 18 weeks
N = 206 (81%)
T
R
E
A
T
M
E
N
T
Figure 2 Flowchart of women through the screening and
recruitment procedures in the RESPOND study. Flow chart of
women invited to participate in the RESPOND study, through the
screening and recruitment procedures, to follow up at 18 weeks.
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ciated with SI. However, SI at baseline was not asso-
ciated with poorer outcome on follow-up, and this
probably reflects the fact that these were women treated
for depression in the RESPOND trial (either by medica-
tion or psychotherapy).
Strengths and Limitations
This study is one of the largest studies of suicidal idea-
tion in women in the postpartum period in the litera-
ture and the only study to compare the EPDS measure
of suicidality with another measure of suicidality (the
CIS-R). The main limitation of this study is that, like all
previous studies, the EPDS suicidality measure is of self
reported thoughts of self harm. Self report may lead to
under-reporting of actual suicidal thoughts, though it is
also possible that self report may more accurately reflect
the truth than clinical interviews. There is some evi-
dence that the rate of SI endorsement on self-adminis-
tered scales can be considerably higher than on
clinician-administered scales in perinatal women [20].
We did not measure suicide attempts (which may be of
more clinical importance), and previous research has
found that 16.7-27.8% of pregnant women referred to a
tertiary clinic for neuropsychiatric evaluation endorsed
SI, but only one attempted suicide [20]. Nevertheless,
there is evidence that suicide ideators and attempters
are a separate but overlapping population from those
who die by suicide [21]. There is therefore value in
investigating suicidal ideas, particularly as much larger
samples would be needed to investigate suicide attemp-
ters in an epidemiologically representative population.
One final caveat though is that the EPDS question on
suicidality (item 10) does not explicitly refer to suicide;
rather it asks about harming oneself. As has been
pointed out in a review of suicidality in the perinatal
period [5], self-harming impulses may or may not reflect
intent to die; other dimensions of suicidality, such as
reasons for dying and reasons for living, are also needed
for more precise risk assessment. The discrepancy found
here between women reporting “hardly ever” having
thoughts of harming themselves on the EPDS but on
the CIS-R reporting that they had thought of killing
themselves in the last week, suggests that women are
not equating the two statements, and item 10 of the
EPDS therefore may not be the best measure of
suicidality.
Other limitations include possible selection bias - our
estimate of prevalence of SI in the screened population
was carried out in women not receiving treatment for
depression and this selection bias needs to be borne in
mind when interpreting our results. In addition, as with
most other studies in this area, the analyses of correlates
of SI were limited by the small numbers reporting SI.
Finally there are limits on the external validity of this
study as our findings on persistence and correlates of SI
were carried out on the women who entered the
RESPOND trial and may not be generalisable to women
outside of a treatment trial.
Implications
The clinical significance of SI as measured by the EPDS
is not entirely clear, as discussed above. Nevertheless,
endorsement of the ‘often’ experiencing SI item on
E P D Sw a sa s s o c i a t e dw i t ha tl e a s tt w oo ft h eC I S - R
items of suicidality. Although it remains unclear
whether the EPDS should be used routinely in perinatal
practice [14], maternity and community services interna-
tionally use this instrument to screen for perinatal
depression. The endorsement of question 10 on suicidal
ideation can cause major concern for healthcare
Table 1 Persistence of Edinburgh Postnatal Depression Scale suicidal ideation (SI) over time
Suicidal ideation (SI) at home visit Total Unadjusted p-value p-value adjusted for
treatment allocation
No Yes
SI at 4 weeks No 155 (91%) 14 (44%) 169
Yes 15 (9%) 18 (56%) 33 < 0.001 < 0.001
Total 170 32 202
SI at 18 weeks No 150 (94%) 29 (85%) 179
Yes 9 (6%) 5 (15%) 14 0.065 0.075
Total 159 34 193
Table 2 Comparison of Clinical Interview Schedule
(Revised version) (CIS-R) and Edinburgh Postnatal
Depression Scale (EPDS) measures of suicidal ideation at
baseline
EPDS Q10 CIS-R
0 1 2 3 4 Total
Never 94 92 23 0 0 209
Hardly Ever 92 8 2 63 0 6 6
Sometimes 41 2 2 18 5 5 0
Often 0 031 2 6
Total 107 132 73 12 7 331
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of depression and score of ≥13 on Edinburgh Postnatal Depression Scale) (n = 253)
All women N = 253 No SI (N = 207) SI
(N = 46)
Unadjusted OR Adj. OR** 95% CI p
Age mean (sd) 28.7 (6.4) 29.1 (6.3) 26.9 (6.5) 0.94 (0.89 - 1.0) 0.78 0.63, 0.97 0.023
Married Yes 105 (44%) 91 (48%) 14 (31%)
No 132 (56%) 100 (52%) 31 (69%) 2.01 (1.01-4.03) 2.39 0.46, 12.45 0.302
Live with partner Yes 184 (73%) 154 (74%) 29 (64%)
No 69 (27%) 53 (26%) 16 (36%) 1.60 (0.81-3.18) 1.06 0.15, 7.22 0.955
Parity 1 96 (38%) 85 (41%) 11 (24%)
2 95 (37%) 75 (36%) 19 (41%) 1.96 (0.88-4.38) 4.58 0.74, 28.33 0.129
3+ 63 (25%) 47 (23%) 16 (35%) 2.63 (1.13-6.13) 15.06 1.55, 146. 53 0.019
Highest qualification* GCSE 67 (27%) 58 (29%) 9 (20%)
A-level 32 (13%) 25 (13%) 6 (14%) 1.55
(0.50-4.81)
3.15 0.34, 28.96 0.312
NVQ 48 (20%) 38 (19%) 10 (23%) 1.70
(0.63-4.56)
1.68 0.24, 11.60 0.601
Degree 61 (25%) 53 (27%) 8 (18%) 0.97
(0.35-2.70)
10.23 0.88, 119 0.063
None 36 (15%) 25 (13%) 11 (25%) 2.84
(1.05-7.69)
0.28 0.02, 3.61 0.327
Mother employed Yes 133 (53%) 118 (58%) 14 (31%)
No 117 (47%) 86 (42%) 31 (69%) 3.03
(1.52-6.05)
0.39 0.06, 2.37 0.306
Partner employed Yes 170 (85%) 146 (89%) 23 (64%)
No 31 (15%) 19 (11%) 13 (36%) 4.58
(1.98-10.60)
3.60 0.55, 23.79 0.315
Ethnicity mother White 196 (78%) 161 (79%) 35 (76%)
Non-White 55 (22%) 44 (21%) 11 (24%) 1.15
(0.54-2.45)
1.70 0.21, 13.99 0.623
Measures at Time 0
GRIMS
1 mean (sd) 15 (6.0) 14 (5.7) 17 (7.0) 1.09
(1.02-1.15)
1.07 0.94, 1.21 0.308
SF12
2 - physical mean (sd) 52.7 (9.4) 53.0 (9.5) 51.9 (8.9) 0.99
(0.95-1.02)
1.04 0.95, 1.14 0.429
SF12 - mental mean (sd) 28.0 (8.3) 28.7 (8.0) 24.4 (9.3) 0.94
(0.89-0.98)
0.90 0.83, 0.98 0.248
EPDS total
3 mean (sd) 17.5 (3.4) 16.7 (2.9) 21.1 (3.3) 1.49
(1.32-1.68)
1.96 1.41, 2.73 < 0.001
*GCSEs are secondary school qualifications taken at 16; A-levels are secondary school qualifications taken at 18; NVQs are National Vocational Qualifications for
adults or young people
**adjusted for all variables
1. GRIMS - Golombok-Rust Inventory of Marital State
2. SF12 - 12-Item Short-Form Health Survey
3. EPDS - Edinburgh Postnatal Depression Scale
Table 4 Suicidal ideation as a predictor of outcome at 18 weeks
Outcome N Coefficient of SI 95% CI of coefficient p-value
Adjusted for baseline measure of outcome and treatment allocation only
Edinburgh Postnatal Depression Scale total score 206 -0.57 -2.74 1.61 0.608
SF-12 Physical Component Score 160 -2.21 -5.63 1.21 0.204
SF-12 Mental Component Score 160 0.96 -3.62 5.54 0.679
Adjusted for baseline measure of outcome, treatment allocation, age, employment, partner employment, marital status
Edinburgh Postnatal Depression Scale total score 145 -1.95 -4.74 0.83 0.167
SF-12 Physical Component Score 113 -1.79 -5.89 2.31 0.389
SF-12 Mental Component Score 113 1.09 -4.52 6.70 0.700
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Page 8 of 10professionals in these settings who do not usually have
mental health training and do not know how to address
this in their clinical practice. They may also be con-
cerned about the impact on patients of being asked
such a question and fear that asking a question about
suicidal thoughts could ‘induce’ suicidal thoughts and
behaviour; however a recent RCT of screening for suici-
dal ideation in primary care found no evidence to sup-
port the view that such screening leads to an increase in
feelings that life is not worth living [22].
This study suggests that these professionals should be
aware that endorsement of “often” will usually mean
there is significant suicidality and depressive symptoma-
tology warranting referral to an appropriate professional
(e.g. general practitioner) for further assessment. How-
ever, suicidal ideation does not appear to predict poor
outcomes in women who are treated for depression.
Women with depressive symptoms and suicidal ideation
should benefit from appropriate treatment for postnatal
depression such as health visitor delivered non-directive
counselling, cognitive behavioural therapy or antidepres-
sants [16]. Women may have strong preferences regard-
ing these treatments and where possible their preferred
treatment should be offered as this may improve out-
come further [16,23,24].
Conclusion
Healthcare professionals using the EPDS should be
aware of the significant suicidality that is likely to be
present in women endorsing ‘yes, quite often’ to ques-
tion 10 of the EPDS. However, suicidal ideation does
not appear to predict poor outcomes in women being
treated for postnatal depression.
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